611218-28-1

Basic information

• Product Name: 2-Propen-1-one, 2-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-(dimethylamino)-
• CAS NO: 611218-28-1
• Molecular Formula: C17H14Cl3NO
• Molecular Weight: 354.663
• Mol File: 611218-28-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-Propen-1-one, 2-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-(dimethylamino)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propen-1-one, 2-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-(dimethylamino)-(611218-28-1)
• EPA Substance Registry System: 2-Propen-1-one, 2-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-(dimethylamino)-(611218-28-1)

Safety Data

• Hazardous Substances Data: 611218-28-1(Hazardous Substances Data)

Upstream product

• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 94171-11-6 2-(4-chlorophenyl)-1-(2,4-dichlorophenyl)ethanone 

Downstream Products

• 1044586-66-4 (4S)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl benzoate 
• 1044586-68-6 MK-5596 
• 1044588-30-8 (4R)-4-azido-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine 
• 1044588-31-9 (4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-amine 
• 1044588-29-5 (4S)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-ol 
• 852316-14-4 methyl 2-(N-(6-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-3-cyanopyridin-2-yl)-N-methylcarbamoyl)acetate 
• 611218-31-6 6-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile 

Relevant articles and documents

SUBSTITUTED PYRANO [2, 3 - B] PYRIDINE DERIVATIVES AS CANNABINOID -1 RECEPTOR MODULATORS

Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present in

SUBSTITUTED NAPHTHYRIDINONE DERIVATIVES

Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present in